Article Topic
Complaint, USA v Xaiofei Chen
United States District Court Western District Of Texas El Paso Division USA v Xaiofei Chen Complaint Filed October 25, 2024 Read the document.
[...]Indictment, USA v Xaiofei Chen
United States District Court Western District Of Texas El Paso Division USA v Xaiofei Chen Indictment Filed November 20, 2024 Read the document.
[...]Indictment, USA v Bhavesh Ranchhodbhai Lathiya and Raxuter Chemicals
United States District Court Eastern District of New York USA v Bhavesh Ranchhodbhai Lathiya and Raxuter Chemicals Indictment Filed December 20, 2024 Read the document.
[...]Indictment, USA v Athos Chemicals PVT LTD
United States District Court Eastern District of New York USA v Athos Chemicals PVT LTD Indictment Filed December 20, 2024 Read the document.
[...]WHO Alert: Counterfeit Cancer Medicines Reported in Europe
Information provided to WHO by AstraZeneca, the genuine manufacturer of IMFINZI, has confirmed that the products identified in this Alert are falsified. Laboratory analysis of samples of the falsified IMFINZI have been carried out by AstraZeneca. The analysis confirmed that the vials of the falsified product contained no active pharmaceutical ingredient.
[...]January 13, 2025: WHO warns about a fake cancer drug with English packaging
WHO reported a fake cancer treatment. This year’s Notorious Markets report focused on fake online pharmacies. Board member Andrea Thomas urged fraternities to stock Narcan.
[...]Complaint, USA v Rui-Siang Lin (Incognito Market)
United States District Court Southern District of New York USA v Rui-Siang Lin Complaint Filed January 26, 2024 Read the document.
[...]FDA Alert: Recall Issued on “Herbal” Diet Pill Containing Prescription and OTC Drug Ingredients
FDA analysis has found these products to contain undeclared Furosemide, Dexamethasone and Chlorpheniramine. Furosemide was found at 5.24 mg/g or 1.84 mg/capsule. Dexamethasone was found at 2.22 mg/g or 0.780 mg/capsule. Chlorpheniramine was found at 4.38 mg/g or 1.54 mg/capsule.
[...]Prescription Drug Affordability Board Activity through December 18, 2024
Prescription Drug Affordability Board Activity through December 18, 2024 Activities Summary Colorado: The Prescription Drug Affordability Board (PDAB) met on December 6, 2024 to hear and discuss public comment before proposing and approving revisions to policy and procedures around affordability reviews. The PDAB updated the state’s Prescription Drug Affordability Review Board and Advisory Council (PDAAC)…
[...]December 16, 2024: Black market medicine in Texas and Tennessee
Two new cases involving black market medicine in Texas and Tennessee, and CPB seized thousands of pills in Laredo.
[...]